Related Experiment Videos
Radioactive seed embolization to the lung following prostate brachytherapy
J C Dafoe-Lambie1, L J Abel, H J Blatt
1Schiffler Oncology Center, Wheeling Hospital, USA.
The West Virginia Medical Journal
|March 29, 2000
Summary
Pulmonary seed embolization occurs in about 20% of patients after prostate brachytherapy. No harmful effects have been observed, but awareness is crucial for patients and providers.
Area of Science:
- Urology
- Radiation Oncology
- Medical Physics
Background:
- Prostate brachytherapy is a common treatment for early-stage prostate cancer.
- A potential complication of this procedure is the migration of radioactive seeds to the lungs.
Purpose of the Study:
- To determine the incidence and timing of radioactive seed migration to the lungs following prostate brachytherapy.
- To assess the clinical significance and potential adverse effects of pulmonary seed embolization.
Main Methods:
- Retrospective analysis of patients who underwent prostate brachytherapy.
- Monitoring for seed migration using imaging techniques.
- Clinical follow-up to evaluate for any adverse events related to seed embolization.
Main Results:
- Pulmonary embolization of radioactive seeds was observed in approximately 20% of patients.
- The seed migration was identified as a risk associated with the procedure.
- No acute or delayed detrimental effects attributable to pulmonary seed embolization have been reported to date.
Conclusions:
- Pulmonary seed embolization is an infrequent but documented event following prostate brachytherapy.
- Current evidence suggests that pulmonary seed embolization is not associated with adverse health outcomes.
- Patients and healthcare providers should be aware of this potential event, although it appears to be clinically insignificant.